Corporate
About ACI
Team
Scientific Advisory Board
Our Approach
ALPHA-1062
Alzheimer's Disease
Cognitive Impairment with Mild Traumatic Brain Injury
ALPHA-0602
Amyotrophic Lateral Sclerosis
ALPHA-0702 and ALPHA-0802 (GEMs)
Our Pipeline
Investors
Stock Info
News
Financials and Filings
Events & Presentations
Investor Relations Contact
Governance
Contact
Menu
Corporate
About ACI
Team
Scientific Advisory Board
Our Approach
ALPHA-1062
Alzheimer's Disease
Cognitive Impairment with Mild Traumatic Brain Injury
ALPHA-0602
Amyotrophic Lateral Sclerosis
ALPHA-0702 and ALPHA-0802 (GEMs)
Our Pipeline
Investors
Stock Info
News
Financials and Filings
Events & Presentations
Investor Relations Contact
Governance
Contact
Investors
News
2023
2023
12.07.2023
Alpha Cognition Announces FDA Acceptance of New Drug Application for ALPHA-1062 for Mild-to-Moderate Alzheimer’s Disease
12.04.2023
Alpha Cognition Announces Amended Terms Of Private Placement And Continuation Of The Offering
11.28.2023
Alpha Cognition Announces Third Quarter and Nine Months Ended September 30, 2023, Results and Provides Corporate Update
11.08.2023
Alpha Cognition Announces Third Closing Of Private Placement And Continuation Of The Offering
10.16.2023
Alpha Cognition Announces Second Closing Of Private Placement And Continuation Of The Offering
09.27.2023
Alpha Cognition Announces Submission of New Drug Application to the FDA for ALPHA-1062 for Mild-to-Moderate Alzheimer’s Disease
08.22.2023
Alpha Cognition Announces Second Quarter and Six Months Ended 2023 Results and Provides Corporate Update
08.10.2023
Alpha Cognition Receives Notice of Allowance for U.S. Patent Application covering use of ALPHA-1062 for Mild to Moderate Alzheimer’s Disease
06.07.2023
Alpha Cognition receives Army Medical Research Grant for Study on mild Traumatic Brain Injury (mTBI) from Blast Induced Functional Deficit and Brain Pathology
05.30.2023
Alpha Cognition Announces First Quarter 2023 Results and Provides Corporate Update
05.19.2023
Alpha Cognition Launches $6.5 Million Private Placement
04.28.2023
CSE Bulletin: New Listing - Alpha Cognition Inc. (ACOG, ACOG.WT)
04.27.2023
Alpha Cognition Announces CSE Listing and TSXV De-listing
03.16.2023
Alpha Cognition Closes Private Placement
03.08.2023
Alpha Cognition Announces Fourth Quarter and Full Year 2022 Results and Provides Corporate Update
03.06.2023
Alpha Cognition Provides Private Placement Update
02.16.2023
Alpha Cognition Closes First Tranche Of Private Placement
02.08.2023
Alpha Cognition Announces $6.8 Million Private Placement
01.19.2023
Alpha Cognition Announces Cancelation and Grant of Stock Options
01.06.2023
Alpha Cognition Announces the Resignation of Chief Medical Officer Cedric O’Gorman, MD
Investors
Quick Links
Stock Info
News
Financials and Filings
Events & Presentations
Investor Relations Contact
Governance
View Video
Read More
Latest News
View All
View All
TSX-V: ACI
15 min delay
Last
$7.77
Change
$-0.28
Open
7.82
Vol
566272
High
7.94
Low
7.67
Stock Information